EGF and urinary bladder neoplasm: This study investigates the effect of the tyrosine kinase inhibitor gefitinib and EGF on the gene expression patterns of two human bladder tumour cell lines, and the subsequent investigation of human early growth response protein 1 (hEGR1) found to be prominently induced by EGF but not in the presence of gefitinib.